Kenneth J Kelley Net Worth & Insider Trades

Kenneth J Kelley - Director, Halozyme Therapeutics, Inc

As of April 14, 2021

What is Kenneth J Kelley's Net Worth?

The current estimated net worth of Halozyme Therapeutics, Inc's Director, Kenneth J Kelley, is estimated to be about $20.41M . Kenneth J Kelley owns about 179,833 units of Halozyme Therapeutics, Inc common stock. In the last 14 years at Halozyme Therapeutics, Inc, Kenneth J Kelley has sold an estimated value of $5.27M worth.

What is Kenneth J Kelley's Past Insider Trading?

Kenneth J Kelley's largest purchase order was 52,629 units , worth over $748.7K on March 19, 2020. Kenneth J Kelley's largest sale order was 35,086 units , worth over $1.44M on December 7, 2020. In total, Kenneth J Kelley has made about 27 transactions over 14 years of their time at Halozyme Therapeutics, Inc. Kenneth J Kelley usually trades in May, with the busiest year in 2020. The most recent transaction was a sale order of 5,000 units , worth over $225K on April 14, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kenneth J Kelley's' Mailing Address?

  • Mailing address is 1331 Hillview Drive Menlo Park CA 94025 CA

Halozyme Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - - - - $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm

What are Halozyme Therapeutics, Inc's Past Insider Trades?

Halozyme Therapeutics, Inc's most recent insider trade came on November 8, 2021 by Helen Torley who sold 50,000 units worth $1.99M . In the last 14 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $131.51M and bought an estimated value of $81.29M worth of shares. Insider trading is most common in May and February, with the busiest year in 2007. The most active traders at the company are Helen Torley, President and CEO,  Gregory Ian Frost, CEO,  and Randal J Kirk .

HALOZYME THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1